Profile data is unavailable for this security.
About the company
Healius Limited is a healthcare company. The Company’s specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers its medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include QML, Laverty, Dorevitch, Western Diagnostic Pathology, TML, Agilex Biolabs, and Abbott Pathology, among others. These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia. It provides specialty diagnostic services to consumers and their referring practitioners.
- Revenue in AUD (TTM)1.34bn
- Net income in AUD-563.00m
- Incorporated1994
- Employees8.00k
- LocationHealius LtdLevel 22Liberty Place, 161 Castlereagh StreetSYDNEY 2000AustraliaAUS
- Phone+61 29432-9400
- Fax+61 29432-9447
- Websitehttps://www.healius.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apiam Animal Health Ltd | 206.92m | 832.00k | 145.62m | -- | 205.57 | 1.17 | 10.69 | 0.7037 | 0.0038 | 0.0038 | 1.11 | 0.6613 | 0.809 | 4.57 | 15.75 | -- | 0.3378 | 1.65 | 0.3896 | 1.93 | 66.22 | 63.46 | 0.4175 | 1.97 | 0.5026 | 2.33 | 0.4586 | 71.37 | 1.11 | 11.83 | -83.13 | -27.29 | 27.96 | 0.3129 |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 200.49m | 42.00 | 9.28 | 0.8297 | 9.76 | 4.38 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
| Monash IVF Group Ltd | 271.92m | 25.01m | 272.74m | 892.00 | 10.97 | 1.11 | 5.72 | 1.00 | 0.0638 | 0.0638 | 0.6947 | 0.6321 | 0.5433 | 3.43 | 9.15 | 304,839.70 | 5.13 | 4.12 | 6.32 | 4.84 | 89.16 | 89.42 | 9.44 | 7.69 | 0.5321 | 6.08 | 0.4182 | 95.49 | 6.65 | 13.34 | 483.15 | 16.36 | 13.96 | 5.80 |
| Australian Clinical Labs Ltd | 741.27m | 32.43m | 465.17m | 4.70k | 13.91 | 2.75 | 2.75 | 0.6275 | 0.174 | 0.174 | 3.90 | 0.8812 | 1.27 | 7.90 | 10.16 | 157,716.80 | 5.62 | 12.05 | 8.84 | 18.53 | 82.70 | 81.44 | 4.43 | 8.79 | 0.4826 | 4.88 | 0.628 | 55.61 | 6.45 | 8.61 | 35.50 | -4.70 | -2.16 | -- |
| Artrya Ltd | 28.00k | -16.41m | 490.06m | -- | -- | 16.51 | -- | 17,502.16 | -0.1782 | -0.1782 | 0.0003 | 0.1878 | 0.0013 | -- | 0.006 | -- | -76.86 | -50.54 | -84.04 | -53.79 | -- | -- | -58,592.86 | -224,202.80 | -- | -- | 0.0285 | -- | -- | -- | -17.19 | -- | 76.21 | -- |
| Healius Ltd | 1.34bn | -563.00m | 562.75m | 8.00k | -- | 0.9572 | -- | 0.4187 | -0.7754 | -0.2082 | 1.85 | 0.8096 | 0.5648 | 6.94 | 7.21 | 168,025.00 | -23.66 | -7.07 | -30.32 | -8.67 | 84.08 | 85.70 | -41.88 | -14.73 | 0.4978 | 0.0031 | 0.608 | -- | 5.69 | -2.90 | 15.97 | -- | -7.13 | -- |
| Australian Unity Ltd | 2.56bn | 29.28m | 577.79m | 7.70k | -- | -- | 5.65 | 0.2256 | -- | -- | -- | -- | 0.2504 | -- | -- | -- | 0.2863 | 0.2535 | -- | -- | -- | -- | 1.14 | 1.08 | -- | 2.32 | 0.3517 | -- | 19.22 | 12.82 | 225.85 | 26.26 | -3.12 | -- |
| Integral Diagnostics Ltd | 627.22m | 4.67m | 895.02m | 3.03k | 200.17 | 1.29 | 14.59 | 1.43 | 0.012 | 0.012 | 2.02 | 1.86 | 0.5779 | 13.49 | 23.69 | 207,343.80 | 0.444 | 0.3746 | 0.4959 | 0.4202 | 95.52 | 95.19 | 0.7683 | 0.668 | 0.6595 | 2.13 | 0.4574 | 568.89 | 33.70 | 17.91 | 107.70 | -27.31 | 18.22 | -7.07 |
| Regis Healthcare Ltd | 1.16bn | 48.95m | 1.88bn | 11.00k | 38.55 | -- | 19.01 | 1.62 | 0.1611 | 0.1611 | 3.82 | -0.0555 | 0.5928 | -- | 46.38 | -- | 2.50 | -0.2222 | -- | -2.22 | -- | -- | 4.22 | -0.4523 | -- | -- | -- | -- | 14.52 | 11.37 | 328.58 | -- | 17.09 | 32.18 |
| Holder | Shares | % Held |
|---|---|---|
| Australian Retirement Trust Pty Ltd.as of 26 Aug 2025 | 87.18m | 12.01% |
| Spheria Asset Management Pty Ltd.as of 30 Oct 2025 | 72.02m | 9.92% |
| First Sentier Investors RQI Pty Ltd.as of 04 Feb 2026 | 50.92m | 7.01% |
| Colonial First State Investments Ltd.as of 01 Dec 2025 | 44.65m | 6.15% |
| Hyperion Asset Management Ltd.as of 30 Oct 2025 | 38.04m | 5.24% |
| Perpetual Investment Management Ltd.as of 27 May 2025 | 36.23m | 4.99% |
| The Vanguard Group, Inc.as of 19 Dec 2025 | 35.80m | 4.93% |
| State Street Global Advisors, Australia, Ltd.as of 03 Feb 2026 | 28.01m | 3.86% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 21.73m | 2.99% |
| First Sentier Investors (Australia) IM Ltd.as of 04 Feb 2026 | 19.44m | 2.68% |
